MYELONEX Trademark
Trademark Overview
On Monday, April 29, 2024, a trademark application was filed for MYELONEX with the United States Patent and Trademark Office. The USPTO has given the MYELONEX trademark a serial number of 98525965. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, November 21, 2024. This trademark is owned by Avstera Therapeutics Corp.. The MYELONEX trademark is filed in the Chemical Products and Computer & Software Services & Scientific Services categories with the following description:
Cells for scientific and research use; Cells for scientific, laboratory or medical research; Biological tissue, namely, blood, stem cells, umbilical cords and placentas for scientific and medical research use; Stem cells for research or scientific purposes; Stem cells for research purposes; Stem cells for scientific and medical research
Research and development in the field of microorganisms and cells; Research in the field of cell engineering technology; Research of induced pluripotent stem cells; Culturing of cells for others for scientific research purposes; Stem cell research services
General Information
| Serial Number | 98525965 |
| Word Mark | MYELONEX |
| Filing Date | Monday, April 29, 2024 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Thursday, November 21, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 10, 2024 |
Trademark Statements
| Goods and Services | Cells for scientific and research use; Cells for scientific, laboratory or medical research; Biological tissue, namely, blood, stem cells, umbilical cords and placentas for scientific and medical research use; Stem cells for research or scientific purposes; Stem cells for research purposes; Stem cells for scientific and medical research |
| Goods and Services | Research and development in the field of microorganisms and cells; Research in the field of cell engineering technology; Research of induced pluripotent stem cells; Culturing of cells for others for scientific research purposes; Stem cell research services |
Classification Information
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, April 29, 2024 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, April 29, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Avstera Therapeutics Corp. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | MALVERN, PA 19355 |
Trademark Events
| Event Date | Event Description |
| Tuesday, April 30, 2024 | NEW APPLICATION ENTERED |
| Wednesday, October 23, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, November 14, 2024 | ASSIGNED TO EXAMINER |
| Friday, November 15, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
